NCT01020903View on ClinicalTrials.gov

Aprepitant for Post-operative Nausea

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Postoperative Nausea
Interventions
PROCEDURE

Aprepitant

40 mg po pre-op

DRUG

Placebo

Orally, pre-op

Trial Locations (1)

10305

Staten Island University Hospital, Staten Island

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
collaborator

Staten Island University Hospital

OTHER

lead

Northwell Health

OTHER

NCT01020903 - Aprepitant for Post-operative Nausea | Biotech Hunter | Biotech Hunter